mariradb adriatic jeanne
Kathrine Selvage
All individuals listed as authors should qualify for authorship and should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. All individuals listed as authors should qualify for authorship and should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
Authors included in the manuscript should meet all of the following conditions as stated in the ICMJE guidelines:
JCCM uses the CRediT Taxonomy to define author contributions. Each author on a paper may have one or more CRediT contribution roles. Author contributions will be included at the end of the manuscript. Having a role described by the taxonomy does not automatically qualify someone as an author.
The journal publishes comprehensive review papers on actual topics of interest related to critical care medicine. Review articles should include a brief non-structured abstract of no more than 300 words and the text should be limited to 5.000 words including references, tables, and figures.
Review articles can be submitted by invitation or unsolicited. In both cases, full consideration will be given to articles providing a substantial contribution to a better understanding of a pathophysiological or clinical aspect in a field related to critical care medicine.
The journal publishes research papers on actual topics of interest related to critical care medicine. These should include a structured abstract of no more than 300 words. The full manuscript should not exceed 5.000 words including references, figures, and tables, being divided into sections headed Introduction, Materials and methods, Results, Discussions, Conclusions.
Case reports should be limited to the presentation of a single particular and uncommon case or uncommon presentation of a disease. Case series include a description of a series of a maximum of 10 cases with common particularities. The abstract should be limited to 200 words, being divided into introduction, case presentation/presentation of case series, and conclusions. The full manuscript should not exceed 2.000 words including references, figures, and tables, being divided into sections headed Introduction, Case presentation/presentation of case series, Discussions, Conclusions. In manuscripts pertaining to case presentation or case series, the number of authors should be limited to four and the number of references to twenty, and the number of figures to 5.
Brief reports refer to articles presenting a short communication related to an original preclinical or clinical study which is not a case presentation or a case series report. While the structure of the abstract and of the full text should be similar to that detailed for full original articles, the length of the manuscript should be shorter, the abstract limited to 200 words, and the full text (including references, tables, and figures) to 2.000 words.
A letter to the editor may refer to an article recently published by the journal, commenting on the article in a constructive professional manner the content of which, in the opinion of the author(s) would add the current status of knowledge in the field. If accepted, the letter will be sent to the authors of the original article who will have the opportunity to respond and to have their response published in the same journal issue as the letter to the editor. The letters should be limited to 500 words, 5 references, and 3 authors. No abstract is required.
Editorials should be limited to 2000 words (including references) and should be related to an article published in the current number or to a specific topic that is current and of high interest to the readers.
The journal publishes state-of-the-art articles that aim to provide an update on the current status of areas of high interest to critical care medical specialists. The principal aim of such articles is to offer the specialist and other practitioners a source of continuing education and forum for discussion. A state-of-the-art article should have a full text limited to 4.000 words, in addition to a 200-word unstructured abstract. Sections of the article should be divided using headings relevant to each particular case.
The cover letter should be signed by the corresponding author who should clearly mention in the letter`s text that he/she is empowered by all the authors to sign the cover letter and submit the manuscript on their behalf.
The cover letter may include a list of potential reviewers or persons which the author(s) do not wish as reviewers. A brief statement of reasons of suitability/non-suitability should be given.
All research studies involving human subjects must have received approval of the appropriate institutional ethics committee and informed consent must be obtained from all the patients participating in the studies, prior to manuscript submission.
In cases where the institutional ethics review committee ruled that approval from them was not required or that the need for informed consent was unnecessary, a statement from the committee to this end should be forwarded to the Editor with the manuscript.
Scientific misconduct includes data fabrication, falsification, plagiarism, redundant publication, ghost authorship or other fraudulent research practices. In order to prevent plagiarism issues, all manuscripts sent to the journal will be screened using anti-plagiarism software. Where there is a suspicion of scientific misconduct, the Editor will act in conformity with the principles stated in the COPE guidelines and if the fraudulent practice is confirmed the manuscript will be rejected outright and without the Editor entering into any further correspondence. If the Editorial Board uncovers possible evidence of such problems, it will first contact the corresponding author in complete confidence, to allow adequate clarification of the situation. If the results of such interactions are not satisfactory, the Board will contact the appropriate official(s) in the institution(s) from which the manuscript originated. It is then left to the institution(s) in question to pursue the matter appropriately. Depending on the circumstances, JCCM may also opt to publish errata, corrections, or retractions.
Serious errors in a published manuscript and infringements of professional ethical codes will result in an article being retracted. All coauthors will be informed about a retraction. A Retraction Note detailing the reason for retraction will be linked to the original article.
In case of manuscripts presenting clinical trials, the clinical trial should be registered in a public trials registry at or before the time of first patient enrollment, as a condition for consideration for publication. Trials should be preferably registered in ClinicalTrials.gov, but any registry that is a primary register of the WHO International Clinical Trials Registry Platform (ICTRP) is acceptable, in accordance with the guidelines of the International Committee of Medical Journal Editors.
Please describe the reason for complaining and specify the address for correspondence. Where the complaint is related to the editorial process, related to a manuscript, please include the name of the manuscript and the date the manuscript was submitted. The Editor in Chief, together with the editorial office will analyze the complaining and will answer your complaint in a maximum of three working days.
The Acute and Critical Care journal adheres completely to the ethical guidelines for research and publication described in the Guidelines on Good Publication ( ), the ICMJE Recommendations ( ), and Principles of Transparency and Best Practice in Scholarly Publishing (joint statement by COPE, DOAJ, WAME, and OASPA; ( ). Furthermore, all processes addressing research and publication misconduct shall follow the flowchart of COPE ( ).
Any investigations involving humans and animals should be approved by the Institutional Review Board and Animal Care Committee, respectively, of the institution at which the study took place. ACC will not consider any studies involving humans or animals without appropriate approval. Informed consent should be obtained, unless waived by the institutional review board, from patients who participated in clinical investigations. Human subjects' names, initials, hospital, dates of birth or other personal or identifying information should not be used. Images of human subjects should not be used unless the information is essential for scientific purposes and explicit permission has been given as part of the consent. Even where consent has been given, identifying details should be omitted if they are not essential. If identifying characteristics are altered to protect anonymity, authors should provide assurances that such alterations do not distort scientific meaning. Formal consents are not required for the use of entirely anonymized images from which the individual cannot be identified- for example, x-rays, ultrasound images, pathology slides or laparoscopic images, provided that these do not contain any identifying marks and are not accompanied by text that might identify the individual concerned. If consent has not been obtained, it is generally not sufficient to anonymize a photograph simply by using eye bars or blurring the face of the individual concerned. If experiments involve animals, the research should be based on national or institutional guidelines for animal care and use. Original articles submitted to ACC that address any investigation involving humans and animals should include a description about whether the study was conducted with approval of the institutional review board (with or without patient informed consent) and animal care committee, respectively, of the institution at which the study was conducted. ACC may also request an approval by the institutional review board or animal care committee for other types of articles when necessary. The content of each article is the responsibility of the authors and not of ACC.
c01484d022